Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender
- People who have painful knee osteoarthritis in one or both knees, confirmed by an X-ray taken within the last year, showing a certain level of joint damage (confirm with trial site for exact scoring details) — or knee arthritis linked to specific inflammatory conditions such as ankylosing spondylitis-related disease or rheumatoid arthritis
- Both knees may be included, either at the same time or at separate times, regardless of how much pain is present
- People who are able to give informed consent themselves, or where someone else can give consent on their behalf if they are physically unable to sign
- People who are registered with the social security system (confirm with trial site which system or country this applies to)
Who may not be able to join:
- The source document does not list separate exclusion criteria — the trial site should be contacted directly for full details on who would not be eligible
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Florent EYMARD, MD, PhD, Assistance Publique - Hôpitaux de Paris
Phone: +33149812701
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes of pain on a 0-100mm VAS from baseline clinical phenotype of OA patients through study completion; Evaluation of the radiological phenotype; Changes of WOMAC score A, B, C and WOMAC total from baseline clinical phenotype of OA patients through study completion; Changes of Lequesne score from baseline clinical phenotype of OA patients through study completion; Changes of quality of life index defined by EQ5D-5L from baseline clinical phenotype of OA patients through study completion; Changes of KOFUS score from baseline clinical phenotype of OA patients through study completion; Changes...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.